Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-098941

Director sold 37,241 shares at $50.45 ($1,878,700)

  • Director acquired 37,241 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GOOD JENNIFER L Director 2024-09-09 Option exercise 10b5-1 +12,900 $22.93 $295,797 15,900 D: show line 1 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise 10b5-1 +4,305 $21.37 $91,998 20,205 D: show line 2 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise 10b5-1 +1,736 $18.99 $32,967 21,941 D: show line 3 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise 10b5-1 +18,300 $4.15 $75,945 40,241 D: show line 4 in the form
GOOD JENNIFER L Director 2024-09-09 Sale 10b5-1 −37,241 $50.45 $1,878,700 3,000 D: show line 5 in the form
Open-market sales · 37,241 sh · avg $50.45 · $1,878,700

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
GOOD JENNIFER L Director 2024-09-09 Option exercise · Stock Option (right to buy) 10b5-1 −12,900 15,000 D: show line 6 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise · Stock Option (right to buy) 10b5-1 −4,305 9,250 D: show line 7 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise · Stock Option (right to buy) 10b5-1 −1,736 7,501 D: show line 8 in the form
GOOD JENNIFER L Director 2024-09-09 Option exercise · Stock Option (right to buy) 10b5-1 −18,300 0 D: show line 9 in the form
Loading xslF345X05/tm2423816-1_4seq1.xml…